On July 7, 2025, the Acquisition Agreement in respect of the Qualifying Transaction was entered into by the Company, Elevate and 1001280684 Ontario Inc. (" Subco "), a wholly-owned subsidiary of the ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 7, 2025 /CNW/ - Applied Graphite ...

Tuesday, July 29,2025 will be the 50th anniversary of the overthrow of General Yakubu Gowon GCFR. He was overthrown in a bloodless military coup on the same Tuesday, July 29, 1975.  Most of us ...

The rejection, based on procedural violations, has created another layer of uncertainty for the embattled opposition party. INEC cited the failure of the notice to be jointly signed by both the ...

ATLANTA - Certification of election results in Georgia is a mandatory duty of local elections officials - not a discretionary ...

CPI(M) raises concerns over Election Commission's voter roll revision in Bihar, likening it to NRC, urging abandonment.

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Government of Nova Scotia has deemed ...

Divisional Railway Manager (DRM), Waltair, Lalit Bohra, on Tuesday felicitated Divisional Traffic Inspectors, Station Masters, Token Porters, and others for their contribution to the successful ...

The 67th Annual Convention of NASA India (EXCLAIM) concluded in grandeur and elegance at the School of Architecture, IPS Academy, Indore. The three-day national event witnessed participation from ...

Kevin Bullock, President and CEO, stated:“We are extremely proud to receive the notice that our Industrial Approval submissions have been deemed complete by the Government of Nova Scotia.

This notice was issued on June 20, 2025, and published in the Hamilton Spectator. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind.

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial ...